Atlas Trials

Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)

Clinical trial NCT03867435 · TERMINATED

Trial details

NCT number
NCT03867435
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Status
TERMINATED
Study type
OBSERVATIONAL
Myotonic Dystrophy Type-1Myotonic Dystrophy Type-2
Start date
2020-02-24
Primary completion
2021-06-03
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.